drugset / Trial / NCT01163227
Effect of AQW051 on Cognitive Function in Patients With Chronic Stable Schizophrenia
RandomizedCrossoverDouble-blindTreatment
Summary
This PoC study is designed to assess the cognitive effects of doses of AQW051 in patients with chronic stable schizophrenia.
Timeline
- Start
- 2010-05
- Primary completion
- 2011-09
- Completion
- 2011-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AQW051 | Small molecule | 2 mg | — |
| Subject | AQW051 | Small molecule | 15 mg | — |
| Subject | AQW051 | Small molecule | 50 mg | — |
| Subject | AQW051 | Small molecule | 100 mg | — |